Manufacturing economics differ: oral bioavailability below 1% drives up API usage and cost, whereas injectables concentrate demand on pen-fill capacity
The expanded approval was based on data from the Phase III EoE KIDS trial, where 66% of children who received the higher dose Dupixent at tiered dosing regimens experienced histological disease remission after 16 weeks of treatment, compared to just 3% in the placebo group, per the press release
Research-Backed Benefits of GLP-1s In clinical trials, GLP-1s lead to weight reductions of 518%, up to 25% after about 5672 weeks of use
The other part is virtual visits
2.Davies M.J., Aroda V.R., Collins B.S., Gabbay R.A., Green J., Maruthur N.M., et al
Sterile ampoules for precision dosing and freshness